CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course

The 2016 revision of the World Health Organization classification of lymphoid neoplasms

(2016) S. H. Swerdlow et al.   BLOOD

Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14

(2016) Mathieu Gallo et al.   VIRCHOWS ARCHIV

CD200 Expression in B-Cell Chronic Lymphoproliferative Disorders

(2016) Nermeen Ahmed El Desoukey et al.   JOURNAL OF INVESTIGATIVE MEDICINE

LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia/small lymphocytic B cell lymphoma

(2015) Thomas Menter et al.   JOURNAL OF CLINICAL PATHOLOGY

SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6

(2015) J Palomero et al.   LEUKEMIA

Mantle cell lymphoma—a spectrum from indolent to aggressive disease

(2015) Birgitta Sander et al.   VIRCHOWS ARCHIV

Differential Expression of CD200 in B-Cell Neoplasms by Flow Cytometry Can Assist in Diagnosis, Subclassification, and Bone Marrow Staging

(2014) Pramoda Challagundla et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and/or 13q14

(2014) Jennifer Chapman-Fredricks et al.   Annals of Diagnostic Pathology

Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network

(2014) Martin Dreyling et al.   LEUKEMIA & LYMPHOMA

CD200 Flow Cytometric Assessment and Semiquantitative Immunohistochemical Staining Distinguishes Hairy Cell Leukemia From Hairy Cell Leukemia-Variant and Other B-Cell Lymphoproliferative Disorders

(2013) Vinodh Pillai et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

SOX11 is a mantle cell lymphoma oncogene

(2013) A. A. Ferrando   BLOOD

SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma

(2013) M. C. Vegliante et al.   BLOOD

Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry

(2013) B. Espinet et al.   CLINICAL CANCER RESEARCH

CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry

(2013) Alex F. Sandes et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Molecular pathogenesis of mantle cell lymphoma

(2012) Pedro Jares et al.   JOURNAL OF CLINICAL INVESTIGATION

Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma

(2011) Daisy Alapat et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis

(2011) S. L. Ondrejka et al.   HAEMATOLOGICA

Indolent mantle cell lymphoma

(2011) M. Furtado et al.   HAEMATOLOGICA

Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas

(2011) Bevan Tandon et al.   MODERN PATHOLOGY

Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

(2010) V. Fernandez et al.   CANCER RESEARCH

The role of CD200 in immunity to B cell lymphoma

(2010) K. K. Wong et al.   JOURNAL OF LEUKOCYTE BIOLOGY

CD200/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells

(2009) Lorenzo Brunetti et al.   BRITISH JOURNAL OF HAEMATOLOGY

CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia

(2009) Giuseppe A. Palumbo et al.   LEUKEMIA RESEARCH

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

(2007) E. Hoster et al.   BLOOD